The talk will delve into how artificial intelligence is reshaping drug discovery. It will discuss the current limitations and challenges in fully leveraging AI to industrialize this field and enable widespread access to treatments. It will spotlight tools like LOWE (LLM-Orchestrated Workflow Engine) for their role in optimizing complex workflows and expediting drug development. Additionally, the talk will emphasize the importance of selecting appropriate inductive biases in designing ML architecture and incorporating human insights to notably improve predictive accuracy to drive innovation on an unprecedented scale.